Several matter pinch shares of The Boeing Company (NYSE:BA) [Trend Analysis], as shares plunging -0.32% to $156.66 with a share volume of 5.61 Million. Biogen (BA) will reduced over 200 employees in Cambridge and Somerville by the end of the year as part of a previously reported plan to stop producing drugs locally, with about half moving to gene therapy manufacturer Brammer Bio, a company spokesman said Tuesday.
The biotech company (Nasdaq: BIIB), which is headquartered at 225 Binney St. in Cambridge, reported in June that it would shutter a nearby 67,000-square-foot manufacturing facility by the end of the year, along with a 46,000-square-foot warehouse in Somerville. After months of searching for a buyer, Biogen recently transferred the assets to Lexington-based Brammer Bio, which will take over beginning in January, the spokesman said. The stock is going forward its 52-week low with 57.17% and moving down from its 52-week high price with -0.85%. To have technical analysis views, liquidity ratio of a company was calculated 1.30 as evaluated with its debt to equity ratio of 5.01. The float short ratio was 3.13%, as compared to sentiment indicator; Short Ratio was 5.52.
Hutchison China MediTech Limited (NASDAQ:HCM) [Trend Analysis] has received notification that Mr Simon To, Executive Director and Chairman, purchased a total of 52,161 American Depositary Shares of the Company “ADSs”, each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med at an average price of US$14.18 per ADS on December 9, 2016, December 12, 2016 and December 13, 2016.
Following the above purchase of 52,161 ADSs, Mr To is interested in 52,161 ADSs and 180,000 Ordinary Shares, representing approximately 0.34% of the current issued share capital of Chi-Med.